Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TK1 | P04183 | 3/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.38 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.38 |
| ▸ | TK2 | O00142 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12464623 | 1.00 | SLC29A1 (0.43) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL9127598 | 1.00 | SLC29A1 (0.43) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL9127601 | 1.00 | SLC29A1 (0.43) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL18025737 | 1.00 | SLC29A1 (0.43) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL18923486 | 0.82 | ADRB1 (0.42) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL16901866 | 0.82 | ADRB1 (0.42) | SLC29A1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL5556184 | 0.81 | SLC29A1 (0.52) | SLC29A1LMNASMN1; SMN2ADRB1DNMT1 | |
| SCHEMBL9127997 | 0.81 | SLC29A1 (0.48) | SLC29A1LMNASMN1; SMN2ADRB1DNMT1 | |
| SCHEMBL9128002 | 0.81 | SLC29A1 (0.48) | SLC29A1LMNASMN1; SMN2ADRB1DNMT1 | |
| SCHEMBL9127726 | 0.80 | ADRB1 (0.46) | LMNASMN1; SMN2ALOX12ADRA1ATK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9416155-B2 | Direct sensing of molecular species by polyfluors on a DNA backbone | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2016-08-16 | — | — | US | disclosed |
| US-20120309107-A1 | Direct Sensing of Molecular Species by Polyfluors on a DNA Backbone | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2012-12-06 | — | — | US | disclosed |
| US-20120309107-A1 | Direct Sensing of Molecular Species by Polyfluors on a DNA Backbone | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2012-12-06 | — | — | US | disclosed |
| WO-2011081939-A1 | DIRECT SENSING OF MOLECULAR SPECIES BY POLYFLUORS ON A DNA BACKBONE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309107-A1 | Direct Sensing of Molecular Species by Polyfluors on a DNA Backbone | ERCC4, POLL, POLQ | SLC29A1 61/4885LMNA 189/4885SMN1; SMN2 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.